Burden of disease in low-risk myelodysplastic syndromes in Spain

Development of an economic model to evaluate the burden of myelodysplastic syndromes over 5 years. Results are obtained in terms of cost and clinical benefit in transfusion-dependent and transfusion-independent patients.

Authors: David Valcárcel, Maria Julia Montoro, Mar Tormo, Joan Bargay, Estela Moreno, Susana Aceituno, Alba Bellmunt, María Soler, Montserrat Rafel, Rocío Villarrubia

Year: 2022

Congress: ISPOR Europe 2022

Download PDF

Subscribe to Outcomes´10

Name *

E-mail *

Todos los campos marcados con un * son obligatorios

Responsible for the data: Outcomes'10, s.l.u., Purpose: Sending commercial communications. Legitimation: Art. 6.1 Consent of the interested party. Recipient: No data is transferred unless expressly authorised. You may exercise your rights on data protection (access, rectification, opposition, deletion, automated decisions, limitation of treatment, portability) by email at dpo@outcomes10.com. Data will be retained for the time necessary to fulfill its purpose and derived responsibilities by current regulations and the deadlines in the applicable regulations on archives and documentation. In any case, you can request the protection of the Spanish Data Protection Agency through its website www.aepd.es/. In addition, you can consult more information on the privacy policy

I have read and accepted the privacy policy